Home DNA test kits should come with a warning, says HFEA
The UK's Human Fertilisation and Embryology Authority is urging companies that offer direct-to-consumer DNA testing to provide more comprehensive warnings to customers...
Qualitative Health Researcher
Rachel Siden is a Volunteer Writer at BioNews. She originally studied Philosophy at the University of Massachusetts, Amherst and went on to obtain an MA in Bioethics and Society from King's College London. She is currently a qualitative health researcher at Stanford University interested in LGBTQ+ health and wellness.
by Rachel Siden
The UK's Human Fertilisation and Embryology Authority is urging companies that offer direct-to-consumer DNA testing to provide more comprehensive warnings to customers...
by Rachel Siden
The Human Fertilisation and Embryology Authority will require fertility clinics to give patients full information about any IVF 'add-on' services being offered to them...
by Rachel Siden
Members of Canada's Stem Cell Network have called for the country to re-examine its laws banning genome editing research on the human germline...
by Rachel Siden
A parliamentary inquiry in Australia is examining the impact of life insurance discrimination based on genetic test results...
by Rachel Siden
The original paper promoting a new genome editing technology known as Natronobacterium gregoryi Argonaute (NgAgo) has been retracted...
by Rachel Siden
China's State Intellectual Property Office has granted the University of California a patent on CRISPR-Cas9 gene editing technology in the country.
by Rachel Siden
Experiments in Democracy recounts the history of human embryo research debates in the United States while exploring how the democratic formulation of policy is impacted by complex relationships between science, bioethics, and the public...
by Rachel Siden
The American College of Medical Genetics and Genomics has published a statement recommending caution over the clinical application of genome editing...
by Rachel Siden
In this podcast, Professor Magdalena Zernicka-Goetz and Sarah Norcross discuss the current UK ban on researching human embryos in the lab for longer than 14 days...
by Rachel Siden
Stem cell therapies could be granted accelerated approval by the US Food and Drug Administration as part of a new bill passed by the Senate last week...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.